SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 539 filers reported holding SEAGEN INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $154,338,870 | -23.7% | 801,927 | -19.7% | 0.18% | -27.7% |
| Q1 2023 | $202,164,270 | +196040.8% | 998,490 | +24.5% | 0.25% | +69.8% |
| Q4 2022 | $103,071 | -99.9% | 802,051 | +29.6% | 0.15% | +18.3% |
| Q3 2022 | $84,689,000 | -56.0% | 618,939 | -43.1% | 0.13% | -52.8% |
| Q2 2022 | $192,335,000 | +7.6% | 1,087,007 | -12.4% | 0.27% | +32.2% |
| Q1 2022 | $178,670,000 | -28.4% | 1,240,331 | -23.1% | 0.20% | -18.5% |
| Q4 2021 | $249,433,000 | -11.0% | 1,613,408 | -2.3% | 0.25% | -19.7% |
| Q3 2021 | $280,281,000 | – | 1,650,652 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |